A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years — Stella

Home/Healthy Adult Male and Female Volunteers/

View on ClinicalTrials.gov

Recruiting

Back to Healthy Adult Male and Female Volunteers trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Celerion, Lincoln, Nebraska

Key details

Phase

Early testing

Sponsor

Centessa Pharmaceuticals (UK) Limited

Enrollment target

~212 participants

Started

February 2026

Primary completion

June 2027

Age range

18 Years – 60 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.